Doctor recommends surprising drink instead of water in a heatwave — and it's not tea
It's good news for anyone going to Glastonbury or Royal Ascot over the coming week, but the spell of warmer weather also comes with warnings.
The UK Health Security Agency (UKHSA) has issued yellow heat health alerts for Midlands and southern England which remain in effect this morning and may continue on into the week.
The government body claimed vulnerable groups may be at risk due to the heat, while an 'increased potential for indoor environments to become very warm' could lead to strain on healthcare services throughout the region.
Alongside warnings to stay out of the midday sun and wear sunscreen, Brits are advised to drink plenty of fluids in order to avoid dehydration.
Before you reach for your water bottle, though, a doctor has claimed there's a better option when managing a heatwave: milk.
It's not the usual go-to come summer; we all remember Anchorman's Ron Burgundy proclaiming 'milk was a bad choice' in the sweltering sunshine, right?.
However, Dr Natasha Fernando, medical director at Medichecks, says it 'may be more hydrating than water'.
'A lot of buildings in the UK aren't well equipped to deal with extreme heat, so it's more important than ever to look after your hydration levels throughout periods of hot weather,' she says. 'However, you don't have to stick to water alone to boost hydration levels.'
Symptoms of dehydration
Symptoms of dehydration in adults and children include:
feeling thirsty
dark yellow, strong-smelling pee
peeing less often than usual
feeling dizzy or lightheaded
feeling tired
a dry mouth, lips and tongue
sunken eyes
If you have symptoms of dehydration drink plenty of fluids (in small sips if you find it hard to drink due to sickness). Additionally, you can get oral rehydration solutions through a pharmacist.
Call 111 urgently if you or your child have any of these symptoms of severe dehydration:
feeling unusually tired or drowsy
confusion or disorientation
feeling dizzy when standing up and it not going away
breathing quickly or a fast heart rate
no tears when crying (specifically applicable to babies and children)
a soft spot on the head than sinks inward, known as sunken fontanelle (specifically applicable to babies and children)
Via NHS.
Dr Natasha explains that due to the sugar, protein, and fat content of milk, which slows the rate at which fluid empties from the stomach, a glass of the white stuff helps you to stay hydrated over longer periods.
'Milk also contains sodium,' she adds, 'which allows your body to hold onto water for longer, aiding hydration levels.'
It's not just cow's milk either: vegan or lactose-intolerant folks can also benefit with a hit of a plant based alternative, and Dr Natasha highlights that 'soya milk also contains electrolytes, which aid re-hydration further.'
Alongside milk, she recommends watermelons, coconut water, cucumbers or cucumber juice, and fresh fruit juices diluted with water to help stay cool.
You've probably heard that a hot drink on a warm day is better too, and while it's a classic older relative refrain, there is some truth to it.
It may not be particularly refreshing, but a steaming cup of tea cools you down by prompting your body to sweat.
'The hot drink somehow has an effect on your systemic cooling mechanisms, which exceeds its actual effect in terms of heating your body,' Peter McNaughton, a neuroscientist at the University of Cambridge told NPR.
'That's probably why chilli peppers are so popular in hot countries because they cause sweating and activate a whole raft of mechanisms which lower the temperature.'
But there is a caveat: your sweat needs to be able to evaporate on your skin. If the air is too humid or you're wearing a lot of clothing, for example, you'll just end up feeling slightly warmer than before you popped the kettle on.
So rather than a milky cuppa, you're probably better off just sticking with the milk.
This article was originally published on July 18, 2024.
Do you have a story to share?
Get in touch by emailing MetroLifestyleTeam@Metro.co.uk.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wales Online
3 hours ago
- Wales Online
Daughters born between two decades warned of increased cancer risk
Daughters born between two decades warned of increased cancer risk UKHSA advises anyone who believes they were exposed to a specific drug before they were born to get checked out as they could have a higher risk of some cancers Thousands of women were prescribed the medication on the NHS to prevent miscarriage and stop breast milk production (Image: GETTY) Diethylstilbestrol was a hormonal therapy drug prescribed to an estimated 300,000 mothers to prevent miscarriages between the 1940s and 1970s before it was discovered that this medication was doing untold damage to the daughters born from these pregnancies. Following an ITV News Investigation earlier this year looking into the link between the drug and cancer cases, health secretary Wes Streeting said that among 'many things that the government is looking at in light of ITV's investigation' was enhanced cancer screening for these women. In an update from the House of Commons, Liberal Democrat Layla Moran questioned the MP about how his department is planning to identify people exposed to Diethylstilbestrol. In response, Labour's Karin Smyth wrote: 'Work has been undertaken to contact historic users of DES. Our sympathies are with anyone harmed by its historic use. The UK Health Security Agency advises that routine cervical screening is appropriate for those who believe they were exposed to DES in utero. Participation in the National Breast Screening Programme is also recommended. 'Pregnant women who know that they were exposed in utero to DES should inform their obstetrician and be aware of the increased risks of ectopic pregnancy and preterm labour. The MHRA continuously assesses the benefit risk balance of all medicines at the time of initial licensing and throughout their use in clinical practice, carefully evaluating any emerging evidence on their benefits and risks.' Her written statement also pointed towards existing guidance on the issue. This notes that only around one case of diethylstilbestrol (DES) exposure is estimated per year in England and Wales. Article continues below It notes: 'Daughters of individuals exposed to DES are at increased risk of clear cell cancer of the cervix and vagina but not other forms of cervical cancer. Granddaughters of those exposed to DES are not at any increased risk of cervical or vaginal cancer.' 'Local arrangements should be made for the follow up of individuals who are DES daughters and have the stigmata of DES exposure. This is usually via annual colposcopy.' The harmful effects of this drug were uncovered in a 1971 study in America, where the FDA promptly banned the medication. The UK's reaction was a bit slower, as the government claimed that a letter was sent out in 1973 telling doctors to stop using the drug for pre-menopausal women. However, the ITV investigation found a number of women who believe they were prescribed the medication as late as 1980. They also found no evidence of the 1973 letter. In response to the ITV News investigation, a Department of Health and Social Care spokesperson said: 'Our sympathies are with anyone harmed by the historic use of Diethylstilboestrol (DES). 'The Secretary of State has been clear he will look seriously at these allegations, and the government will continue to consider enhanced screening for those impacted by the use of this drug.' Article continues below Dr Alison Cave, MHRA Chief Safety Officer, said: "We express our sympathies with those harmed by the historic use of Diethylstilbestrol. We are continuing to invest significant resources to locate historical documentation relating to regulatory decisions on DES made in the 1970s, over 50 years ago. Due to the age and format of the records, this is a complex and time-consuming process.' Since it was found to be harmful, studies on diethylstilboestrol have shown it affected those who were exposed in utero by increasing their risk of rare but serious vaginal and cervical cancer, infetrility and other health problems. More recent studies have also shown women who took the drug may have a 30% higher risk of breast cancer.
Scottish Sun
3 hours ago
- Scottish Sun
New treatment for devastating cancer that DOUBLES survival rate to be rolled out on NHS
'I am going to have an extra few years to see my grandson grow up and maybe even be around to see him get married,' Martyn, who took the new treatment, says 'FIRST IN DECADES' New treatment for devastating cancer that DOUBLES survival rate to be rolled out on NHS Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) THOUSANDS of Brits with bladder cancer could survive for twice as long after a new treatment is given the green light to be dished out on the NHS. Health chiefs have said the approval marks "one of the most hopeful advances in decades for people with bladder cancer". Sign up for Scottish Sun newsletter Sign up 3 In the UK, around 10,500 people are diagnosed with bladder cancer each year Credit: Getty They said there had been real 'unmet need' for patients with the advanced form of the disease. With bladder cancer, up to 29 per cent of people are diagnosed at stage 4, when it has already spread, and only survive for around a year after diagnosis. The treatment is a combination of enfortumab vedotin, an antibody drug made by Astellas and Pfizer, and pembrolizumab, made by Merck. It was approved for use by the National Institute for Health and Care Excellence (Nice) yesterday, which means it can now be used on the NHS for people with bladder cancer. The combination, when tested in clinical trials, gave patients and average of 33.8 months compared with 15.9 months while having chemotherapy. Scientists have also measured the amount of time people that survived without their disease getting worse. They found that those on the treatment had a progression-free survival time of a year compared with six months for those receiving standard treatment. Three in ten patients had no evidence of cancer remaining after the treatment, compared with 14.5 per cent of patients receiving standard care. Martyn Hewett, 75, from Stratford, East London, received the new treatment at Barts Health NHS Trust, after surgery to remove his tumours failed. He said: "I feel very lucky, because if I hadn't been on this trial, I imagine I would be dead by now. The signs and symptoms of cancer "Immediately after the operation that failed, I asked the doctor what the prognosis was, and he said 'most people in your position live for a year', and now, three-and-a-half years later, here I am. "I am going to have an extra few years to see my grandson grow up and maybe even be around to see him get married." The treatment is given via an IV infusion to those whose cancer has spread around their body and cannot be surgically removed. The first drug, enfortumab vedotin, directly targets the cancer cells and kills them, while pembrolizumab helps the immune system to recognise and fight any remaining cancer cells. As well as experiencing better survival rates, patients also have fewer harmful side-effects. About 10,500 people in the UK are diagnosed with bladder cancer each year. The new treatment should help about 1,250 patients annually. Helen Knight, director of medicines evaluation at Nice, said: "This is a highly promising and effective new drug, with clinical trial results highlighting the tremendous difference it could make to the length and quality of people's lives." 3 Martyn Hewett, from London, received the treatment at Barts Health NHS Trust, after a surgery to remove his tumours failed Credit: PA 3 Martyn believes the treatment has given him an extra few years with his grandson Credit: PA Professor Peter Johnson, NHS England's national clinical director for cancer, said: "This is one of the most hopeful advances in decades for people with bladder cancer who will now be offered a treatment that can almost double their chances of survival. "Bladder cancer is often difficult to treat once it has spread, but this new therapy is the first one in years to really help stop the disease in its tracks and our rollout to NHS patients will make a huge difference to the lives of those affected and their families." Jeannie Rigby, chief executive of charity Action Bladder Cancer UK, said: "This new drug has the potential to increase how long people have before their cancer gets worse and how long they live compared with the current, limited, treatment choices available." What causes bladder cancer? The exact causes are unknown, but there are a number of things that can increase your risk factor. Like with many cancers, bladder cancer appear to be caused by exposure to harmful substances, which lead to abnormal changes in the bladder's cells over many years. Tobacco smoke is a common cause and it's estimated that more than one in three cases of bladder cancer are caused by smoking. Contact with certain chemicals previously used in manufacturing is also known to cause bladder cancer. However, these substances have since been banned
Western Telegraph
11 hours ago
- Western Telegraph
Warning over 'dangerous' Listeria-contaminated cheeses
The Spanish Food Safety Agency (AESAN) confirmed on 15 August 2025 that two types of French cheeses - Brie Meule (1 kg) and Camembert Viejo Porche - have tested positive for Listeria monocytogenes. The affected products have been distributed across Spain and are being withdrawn from sale. Spain is the most popular travel destination for Brits, with more than 15 million people from the UK visiting every year, and experts are warning holidaymakers to be extra careful this summer. Mark McShane, Food Hygiene Expert from Food Hygiene Certificate, says: 'Listeria is particularly dangerous because it can grow even at fridge temperatures. "Vulnerable groups such as pregnant women, the elderly, newborns, and those with weakened immune systems face the highest risk. If you have purchased these cheeses in Spain or brought them home from holiday, do not eat them under any circumstances.' AESAN has instructed that anyone in possession of the recalled products should not consume them and instead return them to the point of purchase. Symptoms of listeriosis may include: High fever Muscle aches Nausea Vomiting or diarrhoea In severe cases, the infection can spread beyond the digestive system and become life-threatening. Consumers who have eaten the affected products and feel unwell are advised to seek medical attention immediately. Mark McShane added: 'This is a timely reminder of how important food safety is when travelling abroad. "Always check for official recalls, practise strict hygiene when handling dairy products, and avoid high-risk foods if you are in a vulnerable group.' Recommended reading: What is a food recall? A food recall is when a food product may have to be withdrawn or recalled. A withdrawal is when unsafe food is removed from the supply chain before it has reached consumers. A recall is when unsafe food is removed from the supply chain and consumers are advised to take appropriate action, for example to return or dispose of the unsafe food.
